Valiant Laboratories IPO Details
Issue Date
--
Price Range
₹140
Lot Size
105
IPO Size
₹152.46 Cr
Valiant Laboratories IPO Listing Details
Listing On
6 Oct'23
Issue Price
--
Listed Price
₹ 162.15
Retail Gain/Listing Gain
▲15.82%
Schedule of Valiant Laboratories IPO
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
06/10/2023
Valiant Laboratories Ltd Background
Valiant Laboratories Limited is an active pharmaceutical ingredient (API)/bulk drug manufacturing company, with a focus on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations.
India is the largest provider of generic drugs, globally contributing to approximately 20% of global supply by volume of generic drugs. The overall API industry in India grew from Rs. 781 billion in fiscal 2017 to Rs. 1,179 billion in fiscal 2022, registering a CAGR of 8.5% in rupee terms. Going forward, the API industry is expected to grow at a rate of 9-11% between fiscal 2022 and 2027, largely driven by the increase in API exports. More specifically, the paracetamol API industry (domestic + exports) grew from Rs. 22 billion in fiscal 2017 to Rs. 39 billion in fiscal 2023.
Valiant Laboratories Ltd Competitive Strengths
Strong financial performance
Reducing dependence on imported raw materials
Strategically located manufacturing facility
Risk Factors
- Any changes to the paracetamol API industry or the company’s product demand will adversely affect revenues, financials and profitability.
- The company is dependent on a single manufacturing facility.
- The company must always be subject to strict quality requirements, regular inspections and audits.
Key Strategies
- Diversification into new chemistries.
- Increase penetration into international markets including regulated markets.
- Improve operational efficiencies through backward integration of the proposed facility.
Valiant Laboratories Ltd Key Financials
Here are the key financials for Valiant Laboratories Limited:
How to apply for IPO through ASBA
Kotak Neo
•00m 59s
Valiant Laboratories IPO FAQs
The Valiant Laboratories IPO opens for subscription from [-] to [-], with a total issue size of ₹152.46 Cr. The IPO price band is ₹140 to ₹0 per share with a lot size of 105. The company aims to list the shares on BSE & NSE on 06-10-2023.
The Valiant Laboratories IPO will open for subscription on [-] and will close on [-] for investors.
The minimum lot size for the Valiant Laboratories IPO is 105 equity shares, requiring a minimum investment of ₹14700 for retail investors applying in the IPO.
The price band of the Valiant Laboratories IPO has been fixed at ₹140 to ₹0 per equity share.
You can apply for the Valiant Laboratories IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.
Valiant Laboratories IPO allotment will take place on [-].
You can check the Valiant Laboratories IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.
Valiant Laboratories shares will list on the stock exchanges on 06-10-2023.
The Valiant Laboratories Limited IPO has an issue size of Rs. 152.46 crores. The IPO opens for subscription on 27th September and closes on 3rd October 2023.
Link Intime India Private Limited is the registrar for this IPO.
You may read more about Valiant Laboratories Limited and its IPO from the company’s red herring prospectus (RHP) here:
Trending IPOs
21 May - 25 May'26 | |||||||||
21 May - 25 May'26 | |||||||||
21 May - 25 May'26 | |||||||||
22 May - 26 May'26 | |||||||||
01 Jun - 03 Jun'26 | |||||||||